par Therasse, P.;Mauriac, L;Welnicka-Jaskiewicz, M;Bruning, Peter;Cufer, T;Bonnefoi, H;Tomiak, E;Pritchard, Kathleen;Hamilton, Andrew;Piccart-Gebhart, Martine 
;EORTC Breast Cancer and Early Clinical Studies Groups,
Référence Journal of clinical oncology, 21, 5, page (843-850)
Publication Publié, 2003-03
;EORTC Breast Cancer and Early Clinical Studies Groups, Référence Journal of clinical oncology, 21, 5, page (843-850)
Publication Publié, 2003-03
Article révisé par les pairs
| Titre: |
|
| Auteur: | Therasse, P.; Mauriac, L; Welnicka-Jaskiewicz, M; Bruning, Peter; Cufer, T; Bonnefoi, H; Tomiak, E; Pritchard, Kathleen; Hamilton, Andrew; Piccart-Gebhart, Martine; EORTC Breast Cancer and Early Clinical Studies Groups, |
| Informations sur la publication: | Journal of clinical oncology, 21, 5, page (843-850) |
| Statut de publication: | Publié, 2003-03 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Adolescent |
| Adult | |
| Aged | |
| Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
| Breast Neoplasms -- drug therapy | |
| Breast Neoplasms -- economics | |
| Breast Neoplasms -- pathology | |
| Costs and Cost Analysis | |
| Cyclophosphamide -- administration & dosage | |
| Cyclophosphamide -- therapeutic use | |
| Disease Progression | |
| Disease-Free Survival | |
| Dose-Response Relationship, Drug | |
| Epirubicin -- administration & dosage | |
| Epirubicin -- therapeutic use | |
| Female | |
| Filgrastim -- therapeutic use | |
| Fluorouracil -- therapeutic use | |
| Humans | |
| Middle Aged | |
| Neoadjuvant Therapy | |
| Quality of Life | |
| Survival Rate | |
| Treatment Outcome | |
| Note générale: | Clinical Trial |
| Clinical Trial, Phase III | |
| Comparative Study | |
| Journal Article | |
| Multicenter Study | |
| Randomized Controlled Trial | |
| Review | |
| SCOPUS: ar.j | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0732-183X |
| info:doi/10.1200/JCO.2003.05.135 | |
| info:scp/0037365648 | |
| info:pmid/12610183 |
